Reserpine-hydralazine combination therapy of hypertensive disease, with hydralazine in doses generally below the toxic range.
D000959:Antihypertensive Agents; D003131:Combined Modality Therapy; D006830:Hydralazine; D006973:Hypertension / Q000628:therapy*; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D046948:Secologanin Tryptamine Alkaloids; D013565:Sympatholytics; D006830:Hydralazine; D012110:Reserpine
HYPERTENSION/therapy; RAUWOLFIA ALKALOIDS/therapeutic use; SYMPATHOLYTICS/therapeutic use